Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 32
Phase 41

Trial Status

Completed6
Recruiting2
Other1

Role Distribution

Principal Investigator9
PI Rate100%

Activity Timeline

Clinical Trials (9)

NCT07055217Not ApplicableRecruiting
Effect of Mindfulness-based Neurofeedback for Adolescents With Elevated Repetitive Negative Thinking
NeurofeedbackRepetitive Negative Thinking
PrincipalinvestigatorStart date: 2025-11-04
NCT06765291Not ApplicableRecruiting
Behavioral Intervention for Youth to Promote Vaping Cessation
Nicotine DependenceVapingVaping Teens
PrincipalinvestigatorStart date: 2025-06-18
NCT03655717Not ApplicableCompleted
Using Imaging to Assess Effects of THC on Brain Activity
Intoxication AlcoholIntoxication Combined Alcohol THCIntoxication THC
PrincipalinvestigatorStart date: 2018-11-05
NCT00455650Not ApplicableCompleted
Study of the Effects of Mecamylamine and Varenicline in Schizophrenia
Cognition in Schizophrenia
Principalinvestigator
NCT00621777Phase 4Completed
A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder
Bipolar DisorderSchizoaffective DisorderSchizophrenia+1 more
Principalinvestigator
NCT01399866Phase 3Completed
Cognitive Remediation With D-Cycloserine
Smoking Cessation
Principalinvestigator
NCT01928758Not ApplicableCompleted
Reduced Nicotine Cigarettes in Smokers With Mood and Anxiety Disorders
Tobacco Dependence
Principalinvestigator
NCT06901232Not ApplicableNot Yet Recruiting
Mindfulness-based Neurofeedback to Reduce Negative Thinking in CHARMS Adolescents
Repetitive Negative ThinkingSerious Mental Illness Symptoms
Principalinvestigator

Research Network

Collaboration Network

6 collaborators·5 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jodi M Gilman, PhD

Massachusetts General Hospital

Similar
3 trials

Shared therapeutic areas:

Intoxication AlcoholIntoxication Combined Alcohol THCIntoxication THC+3 more

Worked with same sponsors:

Massachusetts General HospitalNational Institute on Drug Abuse (NIDA)
Collaborated on 1 trial
Similarity Score64%

Susan Whitfield-Gabrieli, PhD

Massachusetts General Hospital

Moderately Similar
2 trials

Shared therapeutic areas:

Repetitive Negative ThinkingNeurofeedbackSerious Mental Illness Symptoms

Worked with same sponsors:

Massachusetts General HospitalNational Institute of Mental Health (NIMH)
Collaborated on 2 trials
Similarity Score38%

Randi M. Schuster, PhD

Massachusetts General Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Nicotine DependenceVapingVaping Teens

Worked with same sponsors:

Massachusetts General HospitalNational Cancer Institute (NCI)
Collaborated on 1 trial
Similarity Score34%

Catherine Fullerton, M.D., M.P.H.

Massachusetts General Hospital

Related
1 trials

Shared therapeutic areas:

Cognition in Schizophrenia

Worked with same sponsors:

Massachusetts General HospitalNational Alliance for Research on Schizophrenia and Depression+1 more
Collaborated on 1 trial
Similarity Score14%

Jonathan A Foulds, PhD

Penn State College of Medicine

Related
1 trials

Shared therapeutic areas:

Tobacco Dependence

Worked with same sponsors:

Milton S. Hershey Medical CenterNational Institute on Drug Abuse (NIDA)
Collaborated on 1 trial
Similarity Score14%

Jamie Ostroff, PhD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

Smoking CessationSmokingTobacco Dependence

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Elliot Stein, Ph.D.

National Institute on Drug Abuse (NIDA)

Related
20 trials

Shared therapeutic areas:

Nicotine DependenceSchizophreniaSmoking Cessation

Worked with same sponsors:

National Institute of Mental Health (NIMH)National Institute on Drug Abuse (NIDA)
Similarity Score6%

Christelle Haziza, PhD

Philip Morris Products S.A.

Related
27 trials

Shared therapeutic areas:

SmokingVaping
Similarity Score4%

Urielle Desalbres

Assistance Publique Hôpitaux de Marseille

Related
71 trials

Shared therapeutic areas:

Bipolar DisorderSchizophrenia
Similarity Score4%

Elisabeth Kruse, PhD

McNeil AB

Related
30 trials

Shared therapeutic areas:

Tobacco DependenceSmoking Cessation
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (9)

Showing 9 of 9 trials

NCT07055217Not ApplicablePrincipalInvestigator

Effect of Mindfulness-based Neurofeedback for Adolescents With Elevated Repetitive Negative Thinking

NeurofeedbackRepetitive Negative Thinking
Recruiting
NCT06765291Not ApplicablePrincipalInvestigator

Behavioral Intervention for Youth to Promote Vaping Cessation

Nicotine DependenceVapingVaping Teens
Recruiting
NCT03655717Not ApplicablePrincipalInvestigator

Using Imaging to Assess Effects of THC on Brain Activity

Intoxication AlcoholIntoxication Combined Alcohol THCIntoxication THC
Completed
NCT00455650Not ApplicablePrincipalInvestigator

Study of the Effects of Mecamylamine and Varenicline in Schizophrenia

Cognition in Schizophrenia
Completed
NCT00621777Phase 4PrincipalInvestigator

A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder

Bipolar DisorderSchizoaffective DisorderSchizophrenia+1 more
Completed
NCT00916721Phase 3PrincipalInvestigator

Memory Reconsolidation Blockade as a Novel Intervention for Nicotine Dependence

Smoking Cessation
Completed
NCT01399866Phase 3PrincipalInvestigator

Cognitive Remediation With D-Cycloserine

Smoking Cessation
Completed
NCT01928758Not ApplicablePrincipalInvestigator

Reduced Nicotine Cigarettes in Smokers With Mood and Anxiety Disorders

Tobacco Dependence
Completed
NCT06901232Not ApplicablePrincipalInvestigator

Mindfulness-based Neurofeedback to Reduce Negative Thinking in CHARMS Adolescents

Repetitive Negative ThinkingSerious Mental Illness Symptoms
Not Yet Recruiting

All 9 trials loaded